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Abstract A large number of human protein-coding genes
are finely regulated by one or more microRNAs. Members
of this small noncoding RNA family have emerged as
important post-transcriptional regulators of gene expres-
sion and are involved in a number of disease phenotypes.
Variability in the human genome is extensive and includes
the common and rare single nucleotide polymorphisms
(SNPs) and copy number variations (CNVs). The func-
tional significance of the genome’s variability is under
intense investigation. In this article we review the emerg-
ing literature on how human genomic variation influences
the outcome of microRNA targeting and the associated
phenotypic effects. Illustrative examples are discussed that
demonstrate the biological importance of functional poly-
morphisms affecting miRNA-mediated gene regulation.
Introduction
The human genome contains many forms of genetic vari-
ation. One class of variants comprises the millions of single
nucleotide polymorphisms (SNPs) first identified more than
30 years ago in the b-globin gene cluster (Kan and Dozy
1978), and recently cataloged in different populations
(Hinds et al. 2005; The International HapMap Consortium
2003). A second common class of variation are copy
number variants (CNVs), also identified about 30 years ago
in the a-globin gene cluster (Goossens et al. 1980; Kan
et al. 1975). A considerable effort is now devoted toward
understanding the extent and magnitude of CNVs in human
populations (Wheeler et al. 2008). Here we review the
emerging evidence of the effect of human genetic variation
on microRNA-mediated gene regulation and discuss how
human interindividual variability can influence the out-
come of microRNA targeting.
miRNAs and their functions
MicroRNAs (miRNAs, miR), which are short, noncoding
RNA molecules (*21 nt), have revealed a new dimension
in the complexity of translation control. Our current
understanding of the functions of miRNAs is incomplete
(Bushati and Cohen 2007). There is considerable evidence
that miRNAs function by binding to complementary
sequences that usually lie in the 30 untranslated regions
(30UTR) of target mRNAs to induce cleavage, repression of
productive translation, and regulation of mRNA stability in
the cytoplasm (Ambros 2004; Bartel 2004; Bushati and
Cohen 2007; Carrington and Ambros 2003; Filipowicz
et al. 2008; Jackson and Standart 2007; Nilsen 2007).
Recently, studies revealed additional functions of miRNAs
such as upregulation of target mRNA translation upon cell-
cycle arrest (Vasudevan et al. 2007), import into the
nucleus (Hwang et al. 2007), or even the secretion of the
miRNAs from the cell (Valadi et al. 2007). A novel aspect
of miRNA-mediated repression with a noncoding transcript
in Arabidopsis thaliana that can regulate the activity of an
miRNA by mimicking its target site has been demonstrated
(Franco-Zorrilla et al. 2007). Some authors suggest that
some RNAs have a nonproductive interaction with a
complementary miRNA to inhibit and regulate the activity
of the miRNA. These examples indicate that miRNA
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molecules have very diverse functions that remain to be
explored.
To date, the miRNA registry (MiRBase) contains 6397
mature miRNAs, among which 678 are human miRNAs
(April 2008, release 11.0). miRNAs can be encoded in
independent transcription units, in polycistronic clusters, or
within the introns of protein-coding genes (Bartel 2004).
Thus far, most registered miRNAs are widely expressed
and highly conserved. Deep sequencing of small RNA
libraries and cell-type–specific analyses are currently
valuable approaches to uncovering miRNAs with less
abundant expression; thus, the catalog of miRNAs is
expected to grow substantially in the future (Bar et al.
2008; Glazov et al. 2008; Sunkar et al. 2008).
miRNA expression profiles indicated that some miRNAs
are under complex control during development and in a
variety of tissues (Farh et al. 2005; Lim et al. 2005; Stark
et al. 2005). These studies suggest that miRNAs define
highly specific cell identities and have a critical role in cell
differentiation. In C. elegans, the miRNA lousy-6 (lsy-6) is
specifically activated by the transcription factor die-1 in
ASE left cells, whereas lsy-6 is downregulated by miR-273
and then activated by the transcription factor cog-1 in ASE
right cells (Chang et al. 2004; Johnston and Hobert 2003;
Johnston et al. 2005). Genetic data demonstrated that lsy-6,
cog-1, miR-273, and die-1 act in a regulatory double-
negative feedback loop (Johnston et al. 2005). This inverse
expression of lsy-6 controls laterality of the nematode
chemosensory system and is an excellent illustration of the
role of miRNAs in controlling terminally differentiated
cellular states.
Although the proteins mediating miRNA biogenesis and
function have been clarified, the precise mechanism by
which miRNAs regulate the expression of target mRNAs
remains unclear. Mature miRNAs preferentially form
nonperfect duplexes with the target mRNA (usually in the
mRNA 30UTR) and recruit a repressing complex termed
the RNA-induced silencing complex (RISC). This regula-
tion can be highly pleitropic, with one miRNA able to
target several hundred different transcripts. In fact, bioin-
formatic prediction indicates that 30% of animal genes may
be miRNA targets.
Principles of miRNA biogenesis
miRNAs are transcribed by RNA polymerase II (Bartel
2004) as long primary transcripts (pri-miRNAs, 100 nt-
10 kb) and are then processed within the nucleus into
hairpin-shaped precursor miRNAs (pre-miRNAs, *70 nt)
by the RNase III enzyme Drosha (Lee et al. 2003) and the
double-stranded RNA-binding domain cofactor DGCR8/
Pasha (DiGeorge syndrome critical region gene 8) (Denli
et al. 2004; Gregory et al. 2004; Han et al. 2004; Landthaler
et al. 2004; Lee et al. 2003). An alternative miRNA pro-
cessing pathway has recently been described that uses
splicing processes to bypass Drosha cleavage and to gen-
erate miRNA precursors from short intronic sequences
(Berezikov et al. 2007; Okamura et al. 2007; Ruby et al.
2007). These small intronic sequences of noncoding RNA
are called mirtrons.
In the cytoplasm, Dicer (RNase III) processes the pre-
miRNAs to generate *22-nt miRNA duplexes (Lund et al.
2004). One strand remains a mature miRNA and is then
assembled into the effector complex RISC (Khvorova et al.
2003; Schwarz et al. 2003).
Principles of miRNA—mRNA interactions
To specify repression, miRNAs seem to require only short
stretches of complementarity to a mRNA, following a broad
set of principles that have been identified experimentally
and by bioinformatic studies (Brennecke et al. 2005; Do-
ench and Sharp 2004; Grimson et al. 2007; Lewis et al.
2005; Lytle et al. 2007; Nielsen et al. 2007). However, the
mechanistic details of miRNA–mRNA interactions are
poorly understood and there are always exceptions that
make the predictions of miRNA targets difficult. Many
studies have confirmed that the interaction is initiated by a
continuous and perfect base pairing of seven contiguous
nucleotides at positions 2-8 from the 50 end of the miRNA,
representing the ‘‘seed region’’ (Lewis et al. 2003, 2005).
Mismatches, a guanine–uracil pairing (GU), or bulges in the
seed sequences disturb the binding of miRNA with this
target site and consequently affect function (Brennecke
et al. 2005). However, it has been observed that an A on
position 1 of the miRNA (50) and either A or U at position 9
can boost miRNA targeting, although these do not need to
base pair with target nucleotides (Grimson et al. 2007).
Other characteristics specify targeting: mismatches and
bulges are present in the central part of the miRNA-target
site duplex, a core region of 30 pairing to residues 13-16
within the miRNA 30 end. However, the degree of repres-
sion is also related to UTR contexts and factors that can
improve site efficiency (Grimson et al. 2007): multiple,
closely spaced target sites act cooperatively, high local AU
content in the vicinity of the miRNA target site improves
site efficiency, and effective sites are located preferentially
near both the poly(A) tail and the stop codon. As part of the
different models proposed for miRNA–mRNA interactions,
miRNA target sites can be categorized into two distinct
classes: 50-dominant and 30-compensatory. 50-Dominant
target sites have perfect base pairing with at least 7-8 nt at
the 50 end of the miRNA; the base pairing to the rest of the
miRNA is considered irrelevant (Chen and Rajewsky 2006;
Lewis et al. 2003). 30-Compensatory target sites have
extended base pairing to the 30 end of the miRNA in order to
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compensate for an imperfect or shorter stretch of base
pairing with the 50 end of the miRNA (Gupta et al. 2006;
Kiriakidou et al. 2004; Schratt et al. 2006; Stark et al. 2005).
Genetic variation
Genetic variations range from large chromosome anoma-
lies to single-nucleotide changes. Recently, multiple
studies have identified a large number of submicroscopic
CNVs of DNA segments ranging from kilobases (kb) to
megabases (Mb) in size (Beckmann et al. 2007). CNVs
consist of deletions, insertions, duplications, and complex
multisite variants in comparison with a reference genome.
All those DNA sequence variations could potentially affect
the maturation of miRNAs, the silencing machinery, the
structure or the expression level of mature miRNA, and the
base pairing at the target site, and have functional role for
miRNA-mediated gene regulation. We focus on human
miRNAs and review all the evidence for human regulatory
polymorphisms perturbing miRNA function and thus in
turn causing phenotypic variations and disorder.
Polymorphisms and heterogeneity
of miRNA sequences
Polymorphism in pri-, pre-, and mature miRNA
sequences
A representative mammalian pri-miRNA comprises a stem
(*33 bp) with a terminal loop and flanking sequences
(*100 bp). Experiments show that a part of the terminal
loop (Zeng and Cullen 2005; Zeng et al. 2005) and
sequences flanking the stem loop (Han et al. 2006; Lee
et al. 2003; Zeng and Cullen 2003) are critical for pro-
cessing by Drosha and Dicer. It has been hypothesized that
polymorphisms in pre-miRNA may influence the miRNA
maturation and thereby modulate miRNA expression.
A total of 173 human pre-miRNAs in 96 Japanese
individuals have been sequenced (Iwai and Naraba 2005).
The study identified ten SNPs in ten pre-miRNA hairpins
among which only one SNP in the mature sequence of
miR-30c-2 is likely to affect stem integrity (this prediction
has not yet been confirmed experimentally).
In another study, a bioinformatic search selected 323
known SNPs located within 227 human pre-miRNA
sequences (Duan et al. 2007). Twelve of these SNPs were
within pre-miRNA sequences and one, a G/U polymor-
phism, located at the eighth nucleotide within the mature
sequence of miR-125a, has been functionally character-
ized. This SNP (rs12975333) blocks in vitro the processing
of pri-miRNA into pre-miRNA and alters the translation
suppression by miR-125a on a well-known Lin-28 target
mRNA. The biological consequences of these miRNA
SNPs remain to be determined.
In a similar study, the occurrence of common SNPs in
474 human pre-miRNAs found by screening the dbSNP
database was studied (Saunders et al. 2007). Sixty-five
SNPs (including indel polymorphisms) in 49 pre-miRNAs
were found, thus exhibiting a SNP density of *1.3 SNPs
per kilobase pair. Only three miRNAs (hsa-mir-125a, hsa-
mir-627, and hsa-mir-662) were found to have SNPs within
the seed region (rs12975333, rs2620381, and rs9745376,
respectively). The conclusion of the study was that miRNA
genes have low polymorphism density and that most
identified polymorphisms are not within the seed region,
indicative of strong selective constraint on human pre-
miRNAs. None of these polymorphisms has been tested
experimentally to determine whether these SNPs might
affect the structure or processing of miRNAs.
A germline DNA variant (C/T) in the primary sequence
of the miRNA cluster encoding for miR-16-1 and miR-15a
(7 bp in the 30 direction after the precursor) has been
identified (Calin et al. 2005). This DNA variant was found
in 11 of 75 patients with chronic lymphocytic leukemia,
but not seen in 160 subjects without cancer. This nucleo-
tide variation results in reduced mature expression of miR-
16-1 and miR-15 in vitro and in vivo and is associated with
deletion of the normal allele containing this miR cluster.
A recent example illustrates how a common polymor-
phism in a miR precursor can consequently affect the
mature miRNA expression level. Jazdzewski et al. (2008)
reported a G/C (rs 2910164) SNP in pre-miR-146a that
results in vitro in reduced amounts of mature miR-146a
and contributes to the genetic predisposition to papillary
thyroid carcinoma.
A recent genome-wide analysis in healthy individuals
revealed 43 miRNAs mapping in CNV regions in one study
(Redon et al. 2006), while another study identified 14
CNVs encompassing 21 known miRNAs (Wong et al.
2007). It is not known if the variation in copy number of
the miRNAs alters their function and contributes to the
phenotypic diversity in humans.
30- and 50-end heterogeneity of miRNAs-isomiRs
Detailed analysis of mature miRNA sequences revealed an
extensive degree of variation at the terminal nucleotides
compared to the current miRBase reference sequences
(Cummins et al. 2006; Lagos-Quintana et al. 2002;
Landgraf et al. 2007; Morin et al. 2008; Ruby et al. 2006;
Wu et al. 2007). This population of variants in known
miRNAs is collectively termed isomiRs. All cited studies
observed in most cases nonrandom and conserved 30-end
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heterogeneity with 30-end deletions and extensions of one
to three nucleotides. The most prevalent type of modifi-
cations generated single-nucleotide 30 extensions that differ
from the genomic sequence. In contrast, 50 ends were more
homogeneous, with only a few cases of variation (Landgraf
et al. 2007; Morin et al. 2008). These results predict that a
particular miRNA hairpin may generate numerous mature
miRNAs.
Although the biological consequence of this observation
remains to be determined, such variants might act by
influencing the miRNA half-life, subcellular localization,
and miRNA target specificity (particularly 50-end varia-
tion). In addition, the most abundant isomiRs’ sequences
need to be determined for each miRNA, and it is essential
to verify whether any of these variants associate within
RISC and function as gene silencers.
Polymorphisms affecting miRNA–mRNA
interactions
Polymorphism in miRNA target sites
The thermodynamics of RNA–RNA interaction plays an
essential role in the binding of a miRNA with its target
mRNA; it is proposed that SNPs at miRNA binding sites
may alter the expression of target genes. Polymorphism
density is significantly lower in conserved target site
regions that are complementary to the seed region of the
miRNA (Chen and Rajewsky 2006). SNPs in this region
are expected to be functional and they are candidates for
causal variants of human disease. Several studies scanned
for the occurrence of SNPs in human 30 UTRs with the
purpose of identifying SNPs that may modulate expression
of computationally predicted miRNA target sites (Bao
et al. 2007; Chen and Rajewsky 2006; Georges et al. 2007;
Saunders et al. 2007). Among the 120,000 known 30 UTR
SNPs, 19,913 modified putative miRNA targets either by
destroying predicted conserved target sites (785) or pre-
dicted nonconserved target sites (9470) or by creating
10,283 novel predicted target sites (http://www.patrocles.
org; Georges et al. 2007).
The first evidence that mutations in a miRNA target site
might affect the phenotype came from a study of the gene
SLITRK1, considered a strong candidate for Tourette’s
syndrome (Abelson et al. 2005). Mutation screening in 174
unrelated individuals with Tourette’s syndrome revealed a
G-to-A transition in the 30 UTR of SLITRK1 that was not
present in 1800 normal individuals. This variant is pre-
dicted to stabilize the interaction of 30 UTR of SLITRK1
with miR-189 by changing a G:U wobble pair to an A:U
Watson-Crick pair at position 9 of the miRNA. It was
demonstrated in vitro that the 30 UTR of SLITRK1 indeed
facilitates miR-189-mediated downregulation of a lucifer-
ase reporter in Neuro2a cells, and the G-to-A variant
resulted in a repression of luciferase expression compared
to the wild type. There is a developmentally regulated and
overlapping expression pattern of SLITRK1 mRNA and
miR-189 in brain regions previously implicated in Tou-
rette’s syndrome (Abelson et al. 2005). Moreover,
SLITRK1 promotes dendritic growth while the mutation
likely results in a loss of function. These results suggest an
association of rare SLITRK1 sequence variants with Tou-
rette’s syndrome (Abelson et al. 2005).
Another example of a functional SNP in the target
miRNA sequence is related to hypertension. A SNP rs5186
(1166A/C) in the 30 UTR for the angiotensin receptor-1
(AGTR1) gene has been characterized (Sethupathy et al.
2007). The 1166C allele of AGTR1 has been shown to
increase the risk of essential hypertension in several asso-
ciation studies in various populations (EHT [MIM
145500]). Moreover, it has been shown independently that
increased levels of AGTR1 contribute to cardiovascular
disease (Song and White 2002; Van Geel et al. 2000) and
antagonists of AGTR1 are now widely used in the treat-
ment of hypertension (Burnier and Brunner 2000). The
likely mechanism through which SNP rs5186 regulates
AGTR1 protein levels has recently been elucidated (Se-
thupathy et al. 2007). This SNP has been localized in a
target site for human miR-155 within the 30 UTR of AGTR1
(Martin et al. 2006). Using reporter silencing assays, it was
shown that miR-155 downregulates the expression of only
the A and not the C allele of rs5186. Thus, the C allele may
be functionally associated with hypertension by abrogating
regulation by miR-155, thereby increasing AGTR1 levels
(Sethupathy et al. 2007). Moreover, miR-155 maps to
human chromosome 21 and it was observed by quantitative
real-time PCR that miR-155 is overexpressed in trisomy 21
individuals. Fibroblasts from monozygotic twins discordant
for trisomy 21 showed that the AGTR1 protein is lower in
trisomy 21 fibroblasts compared to normal. Remarkably, it
has been reported that individuals with trisomy 21 have
lower diastolic and systolic blood pressure levels than age-
and gender-matched controls (Draheim et al. 2002; Mor-
rison et al. 1996). Overexpression of miR-155 in trisomy
21 is likely to excessively suppress the AGTR1 common
allele; this may contribute to the lower blood pressure in
trisomy 21 individuals.
There are four additional examples of loss of miRNA
target site sequences due to SNPs. The presence of SNP
829C/T (rs34764978) in the 30 UTR of DHFR led to a loss
of miR-24 function and resulted in dihydrofolate reductase
overexpression and methotrexate resistance (Mishra et al.
2007). Furthermore, SNP 3142C/G (rs1063320) in the
HLA-G 30 UTR affects the targeting of miR-148a, miR-
148b, and miR-152 and is associated with risk of asthma in
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children (Tan et al. 2007). Wang et al. (2008) demonstrated
a direct link between miR-433 and a common SNP
(rs12720208, T/C) located in the 30 UTR of fibroblast
growth factor 20 (FGF20), already associated with an
increased risk for Parkinson’s disease. The risk allele for
this SNP abolished the miR-433 functional activity and
increased the translation activity of FGF20 and a-synuclein
expression.
Another recent example of loss of miRNA target site
sequences due to SNPs is that type 2 diabetes implicated
miR-657 and the IGF-II receptor gene (IGF2R). IGF2R is
located in a region that has been shown to be related to
insulin resistance and obesity-related metabolic phenotypes
(Duggirala et al. 2001). A case control association study
concluded that the ACAA insertion/deletion (144/140 bp)
polymorphism at the 30 UTR of the IGF2R might partici-
pate in the pathogenesis of type 2 diabetes (Villuendas
et al. 2006). Recently, new evidence showed that hsa-miR-
657 can post-transcriptionally regulate the IGF2R expres-
sion levels in Hep G2 cells by targeting its 30 UTR.
Moreover, it has been demonstrated that the ACAA
insertion/deletion polymorphism alters the interaction
between IGF2R and miR-657 (Lv et al. 2008).
On the other hand, a DNA variant can create a gain of a
miRNA target site. QTL mapping and genetic analysis
reveal a G-to-A substitution in the 30 UTR of the GDF8
gene implicated in the polygenic hypermuscularity of
Texel sheep (Clop et al. 2006). This point mutation creates
two novel target sites for miR-1 and miR-206 (sharing a
common seed sequence), which are highly expressed in
skeletal muscle. In the presence of the mutation, there was
a threefold reduction of circulating myostatin and 1.5-fold
reduction in the GDF8 transcript level. The novel miRNA
target sites were also experimentally validated.
Polymorphisms affecting miRNA expression
To date there are no SNPs described that affect miRNA
expression levels. It is anticipated that such variation will
be discovered in the near future as the miRNAs are better
characterized, and more genomic variants, common or rare,
will be functionally analyzed and be associated with
phenotypes.
Conclusions
The study of SNPs has revealed that any two randomly
selected human genomes differ by 0.1% (Frazer et al.
2007). A fraction of this genetic variation would affect
functional elements directly and will have a causative role
in the phenotype. It is therefore expected that genetic
variability would also affect the function of miRNAs. This
review points out the emergence of a new class of regu-
latory variability that might substantially contribute to the
heritability of complex traits. Some illustrative examples
have been discussed here. However, the majority of this
functional variability (particularly rare private variants)
may remain unknown. The miRNA function provides
excellent opportunities for the discovery of potential epi-
static interactions between polymorphisms in miRNA
genes and their targets as important risk allele combina-
tions. Because miRNAs affect the fine-tuning of gene
expression, we predict that functional variants related to
miRNA biology will likely be involved in the complex
multifactorial phenotypes.
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